FN Archimer Export Format
PT J
TI Producing recombinant commercial proteins
OT Les microalgues : usines cellulaires productrices de molécules commerciales recombinantes
BT 
AF CADORET, Jean-Paul
   BARDOR, M
   LEROUGE, P
   CABIGLIERA, M
   HENRIQUEZ, Vitalia
   CARLIER, Aude
AS 1:1;2:2;3:2;4:;5:3;6:1;
FF 1:PDG-DOP-DCB-BM-PBA;2:;3:;4:;5:PDG-DOP-DCB-BM-PBA;6:PDG-DOP-DCB-BM-PBA;
C1 Ctr Nantes, IFREMER, Lab PBA, F-44311 Nantes 03, France.
   Univ Rouen, CNRS, UMR 6037, IFRMP 23,Fac Sci, F-76821 Mont St Aignan, France.
   Pontificia Univ Catolica Chile, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile.
C2 IFREMER, FRANCE
   UNIV ROUEN, FRANCE
   PONTIFICIA UNIV CATOLICA CHILE, CHILE
SI NANTES
SE PDG-DOP-DCB-BM-PBA
IN WOS Ifremer jusqu'en 2018
   copubli-france
   copubli-univ-france
   copubli-int-hors-europe
   copubli-sud
IF 0.59
TC 20
UR https://archimer.ifremer.fr/doc/2008/publication-4045.pdf
   https://archimer.ifremer.fr/doc/2008/sup-4045.pdf
LA English
DT Article
DE ;genetics;recombinant;algae;pharmaceuticals;gene transfer;Biotechnology;génétique;recombinant;algues;pharmaceutique;transfert de gène;Biotechnologie
AB Extraction of natural substances and chemical synthesis are the main sources of pharmaceutical molecules. When possible, one may transfer the gene of the molecule in living cells creating individual factories producing on demand and in a safe way the requested molecule. Today, bacteria, yeast, mammalian cells and plants constitute the main plate-forms for various commercial products. Microalgae present numerous advantages and could offer a powerful tool for the production of commercial molecules in a near future.
PY 2008
PD APR
SO MS Médecine Sciences
SN 0767-0974
PU EDK
VL 24
IS 4
UT 000255451900013
BP 375
EP 382
ID 4045
ER

EF